Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. - Wikidata - awgldk - TriplyDB

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.

http://www.wikidata.org/entity/Q33426377

about

ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro Idiopathic thrombotic thrombocytopenic purpura: strongest risk factor for relapse from remission is having had a relapse.Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.Mechanisms of Autoantibody-Induced Pathology.Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.ADAMTS-13 and von Willebrand factor: a dynamic duo.A New Classification System for IgG4 Autoantibodies.Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.Thrombotic thrombocytopenic purpura

P2860

Q33431193-3FA55CBE-8064-40FE-BB27-09EF43606382 Q33434516-37D79C42-5808-437C-A617-9E127645F335 Q33436972-0B2EBAEF-F617-42A2-A900-F5B473621FE5 Q33740580-510C3D2F-D6FD-44C9-AD78-D88045E7F75B Q36091783-F6EC238C-50FB-4193-AFF5-05612A31BB94 Q47128233-53FCE9A1-5920-4D6E-AED6-C9D41D3FCCE5 Q50135856-E0A4258C-061D-4FD7-B2F9-52FD29608A94 Q50327901-CA7C2C97-560A-43DF-9131-A98D669B3B59 Q52576561-47BFE6AC-7DEF-40C0-9CE9-4F122A83AEA7 Q57379903-D615654D-0FA8-43E0-95A5-F193E9AD7782

P2860

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.

http://www.wikidata.org/entity/Q33426377

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@ast

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@en

type

label

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@ast

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@en

prefLabel

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@ast

Pathogenicity of Anti-ADAMTS13 ...... otic Thrombocytopenic Purpura.

@en

P1433

Q33426377-9254CDBD-EC37-4D9C-B719-318A104C4253

P1476

Q33426377-7D6E45A1-53A3-4DF7-B791-2EE7AB3ECC3E

P2093

Q33426377-03E07B4F-1DAC-4FED-8EF9-9FDB51035887

Q33426377-5840B03A-23F9-42D7-AE0E-D8C1791B66F7

Q33426377-F45986B1-66E3-48B2-BA04-576B936FE520

P2860

Q33426377-0A08E222-E249-42D3-8E65-7D8A9F5172CF

Q33426377-0FCEED21-55D3-4C9C-BB15-5B5D7FC706E1

Q33426377-158220D3-B06D-481A-9840-EC9B755CBE62

Q33426377-1F4A6907-E73C-494C-81A1-EEA9FDCB68C5

Q33426377-1F96F84D-4B38-4C58-8F18-822793F32195

Q33426377-22815A18-6C5E-46D6-93F0-CF2BFB686C01

Q33426377-2582B306-7F5F-466A-916B-5AB31FE687A1

Q33426377-3AE2538B-307D-4D8F-8F66-840657AB77F7

Q33426377-432D788F-39D6-42D7-8C56-38E7E0BB9169

Q33426377-43842C0F-FEE5-4C66-A340-D9E4D915419A

P304

Q33426377-C4145E23-62D8-4BB2-BDB5-CBABE5B0DC79

P31

Q33426377-F01DB495-BE42-4F0B-A183-555C29C7BA83

P356

Q33426377-BC9869E8-0E7B-48F1-939B-3B24313627B7

P433

Q33426377-6A2F8513-FCA3-4F4E-86E5-BB97C3711090

P478

Q33426377-B181F0E3-313E-495D-9F32-4E5852E8C41A

P50

Q33426377-4CE85A01-F4B1-4315-8231-2636A56A41EE

P577

Q33426377-302742AA-38F5-43C3-8B31-B930DC48B22A

P5875

Q33426377-661FB58C-9F53-4F59-89B9-74A6A430F649

P698

Q33426377-FA28C42D-F4DF-4807-8395-4D27610DFB56

P921

Q33426377-8CB01D67-4ADE-44B9-A3EE-E71784319309

Q33426377-EE79A37D-826A-4072-9449-253B7AF3D4B9

P932

Q33426377-43CA7BE6-F165-4EFF-AC85-C895DBF0B735

P356

J.EBIOM.2015.06.007

P1433

P1476

Pathogenicity of Anti-ADAMTS13 ...... botic Thrombocytopenic Purpura

@en

P2093

Mari R Thomas

http://www.w3.org/2001/XMLSchema#string

Marie A Scully

http://www.w3.org/2001/XMLSchema#string

Rens de Groot

http://www.w3.org/2001/XMLSchema#string

P2860

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.

Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.

Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.

ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.

Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.

P304

942-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2015.06.007

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

James T B Crawley

P577

2015-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278050531

http://www.w3.org/2001/XMLSchema#string

P698

26425702

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

4563118

http://www.w3.org/2001/XMLSchema#string